Molecular toxicology and carcinogenesis of fumonisins: a review

References

• Bezuidenhout SC, Gelderblom WCA, Gorst-Allman CP, et al. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme. Int Symp Chem Nat Prod. 1988;1988:217. doi:10.24496/intnaturalprod.1988.0_217.
   Google Scholar
• Gelderblom WC, Jaskiewicz K, Marasas WF, et al. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol. 1988;54(7):1806–1811. doi:10.1128/AEM.54.7.1806-1811.1988.
   Google Scholar
• Marasas WF. Discovery and occurrence of the fumonisins: a historical perspective. Environ Heal Perspect. 2001;109(Suppl 2):239–243. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240671/. doi:10.2307/3435014.
   Google Scholar
• Ross PF, Ledet AE, Owens DL, et al. Experimental equine leukoencephalomalacia, toxic hepatosis, and encephalopathy caused by corn naturally contaminated with fumonisins. J Vet Diagn Invest. 1993;5(1):69–74. doi:10.1177/104063879300500115.
   Google Scholar
• Thiel PG, Sydenham EW, Shephard GS, et al. Study of the reproducibility characteristics of a liquid-chromatographic method for the determination of fumonisins b-1 and b-2 in corn - IUPAC collaborative study. J AOAC Int. 1993;76(2):361–366. doi:10.1093/jaoac/76.2.361.
   Google Scholar
• Nelson PE, Plattner RD, Shackelford DD, Desjardins AE. Fumonisin B1 production by Fusarium species other than F. moniliforme in section Liseola and by some related species. Appl Environ Microbiol. 1992;58(3):984–989. doi:10.1128/aem.58.3.984-989.1992.
   Google Scholar
• Nelson PE, Desjardins AE, Plattner RD. Fumonisins, mycotoxins produced by fusarium species: biology, chemistry, and significance. Annu Rev Phytopathol. 1993;31:233–252. doi:10.1146/annurev.py.31.090193.001313.
   Google Scholar
• Onyike NBN, Nelson PE. Fusarium species associated with sorghum grain from Nigeria, Lesotho, and Zimbabwe. Mycologia. 1992;84(3):452–458. doi:10.2307/3760198.
   Google Scholar
• Wang E, Ross PF, Wilson TM, Riley RT, Merrill AH. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J Nutr. 1992;122(8):1706–1716. doi:10.1093/jn/122.8.1706.
   Google Scholar
• Merrill AH, Vanechten G, Wang E, Sandhoff K. Fumonisin-B(1) inhibits sphingosine (sphinganine) n-acyltransferase and de-novo sphingolipid biosynthesis in cultured neurons in-situ. J Biol Chem. 1993;268(36):27299–27306.
   Google Scholar
• Merrill AH, Jr, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Heal Perspect. 2001;109:283–289. doi:10.2307/3435020.
   Google Scholar
• Voss KA, Howard PC, Riley RT, Sharma RP, Bucci TJ, Lorentzen RJ. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides). Cancer Detect Prev. 2002;26(1):1–9. doi:10.1016/S0361-090X(02)00011-9.
   Google Scholar
• Riley RT, Merrill AH, Jr. Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease. J Lipid Res. 2019;60(7):1183–1189. doi:10.1194/jlr.S093815.
   Google Scholar
• Haliburton JC, Buck WB. Equine leucoencephalomalacia: an historical review. In: Richard JL, Thurston JR, eds. Diagnosis of Mycotoxicoses. Current Topics in Veterinary Medicine and Animal Science. Vol. 33. Dordrecht: Springer; 1986:75–76. 10.1007/978-94-009-4235-6_7
   Google Scholar
• Diaz GJ, Boermans HJ. Fumonisin toxicosis in domestic-animals - a review. Vet Hum Toxicol. 1994;36(6):548–555.
   Google Scholar
• Haschek WM, Gumprecht LA, Smith G, Tumbleson ME, Constable PD. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Health Perspect. 2001;109(Suppl. 2):251–257. doi:10.1289/ehp.01109s2251.
   Google Scholar
• Ahangarkani F, Rouhi S, Gholamour Azizi I. A review on incidence and toxicity of fumonisins. Toxin Rev. 2014;33(3):95–100. doi:10.3109/15569543.2013.871563.
   Google Scholar
• Cawood ME, Gelderblom WCA, Alberts JF, Snyman SD. Interaction of c-14-labeled fumonisin-b mycotoxins with primary rat hepatocyte cultures. Food Chem Toxicol. 1994;32(7):627–632. doi:10.1016/0278-6915(94)90006-X.
   Google Scholar
• Gelderblom WCA, Cawood ME, Snyman SD, Marasas WFO. Fumonisin B-1 dosimetry in relation to cancer initiation in rat-liver. Carcinogenesis. 1994;15(2):209–214. doi:10.1093/carcin/15.2.209.
   Google Scholar
• Riley RT, Voss KA, Yoo KS, Gelderblom WCA, Merrill AH. Mechanism of fumonisin toxicity and carcinogenesis. J Food Prot. 1994;57(7):638–645. doi:10.4315/0362-028x-57.7.638.
   Google Scholar
• Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis. 1991;12(7):1247–1251. doi:10.1093/carcin/12.7.1247.
   Google Scholar
• Fincham J, Marasas W, Taljaard J, et al. Atherogenic effects in a non-human primate of Fusarium moniliforme cultures added to a carbohydrate diet. Atherosclerosis. 1992;94(1):13–25. doi:10.1016/0021-9150(92)90183-H.
   Google Scholar
• Qureshi MA, Heggen CL, Hussain I. Avian macrophage: effector functions in health and disease. Dev Comp Immunol. 2000;24(2–3):103–119. doi:10.1016/S0145-305X(99)00067-1.
   Google Scholar
• Rheeder JP, Marasas WFO, Vismer HF. Production of fumonisin analogs by fusarium species. Appl Environ Microbiol. 2002;68(5):2101–2105. doi:10.1128/AEM.68.5.2101-2105.2002.
   Google Scholar
• Musser SM, Gay ML, Mazzola EP, Plattner RD. Identification of a new series of fumonisins containing 3-hydroxypyridine. J Nat Prod. 1996;59(10):970–972. doi:10.1021/np960349t.
   Google Scholar
• Seo J-A, Kim J-C, Lee Y-W. N-acetyl derivatives of type C fumonisins produced by Fusarium oxysporum. J Nat Prod. 1999;62(2):355–357. doi:10.1021/np980371h.
   Google Scholar
• Humpf HU, Voss KA. Effects of thermal food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol Nutr Food Res. 2004;48(4):255–269. doi:10.1002/mnfr.200400033.
   Google Scholar
• Voss KA, Smith GW, Haschek WM. Fumonisins: toxicokinetics, mechanism of action and toxicity. Anim Feed Sci Technol. 2007;137(3–4):299–325. doi:10.1016/j.anifeedsci.2007.06.007.
   Google Scholar
• Hu L, Liu H, Yang J, et al. Free and hidden fumonisins in raw maize and maize-based products from China. Food Addit Contam Part B Surveill. 2019;12(2):90–96. doi:10.1080/19393210.2018.1564371.
   Google Scholar
• Dall'Asta C, Galaverna G, Mangia M, Sforza S, Dossena A, Marchelli R. Free and bound fumonisins in gluten-free food products. Mol Nutr Food Res. 2009;53(4):492–499. doi:10.1002/mnfr.200800088.
   Google Scholar
• Sydenham E, Shephard GS. Chromatographic and allied methods of analysis for selected mycotoxins. In: Gilbert J, ed. Progress in Food Contaminant Analysis. London: Blackie Publishers; 1996:65–146.
   Google Scholar
• Turner NW, Subrahmanyam S, Piletsky SA. Analytical methods for determination of mycotoxins: a review. Anal Chim Acta. 2009;632(2):168–180. doi:10.1016/j.aca.2008.11.010.
   Google Scholar
• European Commission, EC. Commission regulation 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in foodstuff. Official Journal of the European Union. http://extwprlegs1.fao.org/docs/pdf/eur68134.pdf. Published 2006. Accessed November 24, 2020.
   Google Scholar
• USFDA. Guidance for Industry: Fumonisin Levles in Human Foods and Animal Feeds. Nutrition C for FS and A, ed. 2001. https://www.fda.gov/RegulatoryInformation/Guidances/ucm109231.htm. Accessed November 24, 2020.
   Google Scholar
• Riley RT, Norred WP, Bacon CW. Fungal toxins in foods: recent concerns. Annu Rev Nutr. 1993;13:167–189. doi:10.1146/annurev.nu.13.070193.001123.
   Google Scholar
• Nijs M, Egmond HP, Rombouts FM, Notermans SHW. Identification of hazardous Fusarium secondary metabolites occurring in food raw materials. J Food Safety. 1997;17(3):161–191. doi:10.1111/j.1745-4565.1997.tb00185.x.
   Google Scholar
• Farhadi A, Nowrozi H, Kachuei R. Metabolism, toxicity, detoxification, occurrence, intake and legislations of fumonisins - a review. JPRI. 2019;29(6):1–35. doi:10.9734/jpri/2019/v29i630252.
   Google Scholar
• Kamle M, Mahato DK, Devi S, Lee KE, Kang SG, Kumar P. Fumonisins: impact on agriculture, food, and human health and their management strategies. Toxins (Basel). 2019;11(6):328. doi:10.3390/toxins11060328.
   Google Scholar
• IARC. International agency for research on cancer monographs on the evaluation of carcinogenic risks to humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Lyon, France: World Health Organization. Vol. 8. 2002:227–338. https://monographs.iarc.fr/ENG/Monographs/vol82/mono82.pdf. Accessed February 17, 2018.
   Google Scholar
• Wielogorska E, Mooney M, Eskola M, et al. Occurrence and human-health impacts of mycotoxins in Somalia. J Agric Food Chem. 2019;67(7):2052–2060. doi:10.1021/acs.jafc.8b05141.
   Google Scholar
• Marasas WFO, Riley RT, Hendricks KA, et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr. 2004;134(4):711–716. doi:10.1093/jn/134.4.711.
   Google Scholar
• Abdallah MF, Krska R, Sulyok M. Occurrence of ochratoxins, fumonisin B2, aflatoxins (B1 and B2), and other secondary fungal metabolites in dried date palm fruits from Egypt: a mini-survey. J Food Sci. 2018;83(2):559–564. doi:10.1111/1750-3841.14046.
   Google Scholar
• Vismer HF, Shephard GS, Rheeder JP, van der Westhuizen L, Bandyopadhyay R. Relative severity of fumonisin contamination of cereal crops in West Africa. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(11):1952–1958. doi:10.1080/19440049.2015.1084654.
   Google Scholar
• Cano-Sancho G, Ramos AJ, Marin S, Sanchis V. Occurrence of fumonisins in Catalonia (Spain) and an exposure assessment of specific population groups. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(5):799–808. doi:10.1080/19440049.2011.644813.
   Google Scholar
• Esposito F, Fasano E, Scognamiglio G, Nardone A, Triassi M, Cirillo T. Exposure assessment to fumonisins B1, B2 and B3 through consumption of gluten-free foodstuffs intended for people affected by celiac disease. Food Chem Toxicol. 2016;97:395–401. doi:10.1016/j.fct.2016.10.013.
   Google Scholar
• Kumi J, Mitchell NJ, Asare GA, et al. Aflatoxins and fumonisins contamination of home-made food (weanimix) from cereal-legume blends for children. Ghana Med J. 2014;48(3):121–126. doi:10.4314/gmj.v48i3.1.
   Google Scholar
• Magoha H, Kimanya M, De Meulenaer B, Roberfroid D, Lachat C, Kolsteren P. Risk of dietary exposure to aflatoxins and fumonisins in infants less than 6 months of age in Rombo, Northern Tanzania. Matern Child Nutr. 2016;12(3):516–527. doi:10.1111/mcn.12155.
   Google Scholar
• Dupre TV, Siskind LJ. The role of sphingolipids in acute kidney injury. Adv Biol Regul. 2018;70:31–39. doi:10.1016/j.jbior.2018.11.003.
   Google Scholar
• Lynch DV, Sphingolipids V. Sphingolipids. In: Thomas s Moore (ed.) Lipid Metabolism in Plants, Boca Raton, FL: Taylor & Francis Group; 2018:285–308. doi:10.1201/9781351074070.
   Google Scholar
• Zitomer NC, Mitchell T, Voss KA, et al. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J Biol Chem. 2009;284(8):4786–4795. doi:10.1074/jbc.M808798200.
   Google Scholar
• Abnet CC, Borkowf CB, Qiao Y, et al. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China. Cancer Causes Control. 2001;12(9):821–828.
   Google Scholar
• Gelineau-van Waes J, Rainey MA, Maddox JR, et al. Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720. Birth Defects Res A Clin Mol Teratol. 2012;94(10):790–803. doi:10.1002/bdra.23074.
   Google Scholar
• Gardner NM, Riley RT, Showker JL, et al. Elevated nuclear sphingoid base-1-phosphates and decreased histone deacetylase activity after fumonisin B1 treatment in mouse embryonic fibroblasts. Toxicol Appl Pharmacol. 2016;298:56–65. doi:10.1016/j.taap.2016.02.018.
   Google Scholar
• Delongchamp R, Young J. Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Food Addit Contam. 2001;18(3):255–261. doi:10.1080/02652030118953.
   Google Scholar
• Enongene EN, Sharma RP, Bhandari N, et al. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol Sci. 2002;67(2):173–181. doi:10.1093/toxsci/67.2.173.
   Google Scholar
• Merrill AH, Jr, Morgan ET, Nikolova-Karakashian M, Stewart J. Sphingomyelin hydrolysis and regulation of the expression of the gene for cytochrome P450. Biochem Soc Trans. 1999;27(4):383–387. doi:10.1042/bst0270383.
   Google Scholar
• van Meer G, Hoetzl S. Sphingolipid topology and the dynamic organization and function of membrane proteins. FEBS Lett. 2010;584(9):1800–1805. doi:10.1016/j.febslet.2009.10.020.
   Google Scholar
• Kim SH, Singh MP, Sharma C, Kang SC. Fumonisin B1 actuates oxidative stress-associated colonic damage via apoptosis and autophagy activation in murine model. J Biochem Mol Toxicol. 2018;32(7):e22161–8. doi:10.1002/jbt.22161.
   Google Scholar
• Liu X, Fan L, Yin S, Chen H, Hu H. Molecular mechanisms of fumonisin B1-induced toxicities and its applications in the mechanism-based interventions. Toxicon. 2019;167:1–5. doi:10.1016/j.toxicon.2019.06.009.
   Google Scholar
• Tsalamandris S, Vogiatzi G, Antonopoulos ASS, Tousoulis D. The role of oxidative stress. In: Dimitris Tousoulis (ed.) Coronary Artery Disease: From Biology to Clinical Practice. London, UK: Elsevier Inc.; 2018:95–100. doi:10.1016/b978-0-12-811908-2.00006-4.
   Google Scholar
• Betteridge DJ. What is oxidative stress? Metabolism. 2000;49(2 Suppl 1):3–8. doi:10.1016/S0026-0495(00)80077-3.
   Google Scholar
• Poersch AB, Trombetta F, Braga ACM, et al. Involvement of oxidative stress in subacute toxicity induced by fumonisin B1 in broiler chicks. Vet Microbiol. 2014;174(1–2):180–185. doi:10.1016/j.vetmic.2014.08.020.
   Google Scholar
• Wangia RN, Githanga DP, Xue KS, Tang L, Anzala OA, Wang JS. Validation of urinary sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children. Biomarkers. 2019;24(4):379–388. doi:10.1080/1354750x.2019.1587510.
   Google Scholar
• Stockmann-Juvala H, Mikkola J, Naarala J, Loikkanen J, Elovaara E, Savolainen K. Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures. Free Radic Res. 2004;38(9):933–942. doi:10.1080/10715760412331273205.
   Google Scholar
• Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, Creppy EE. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology. 2005;213(1–2):56–65. doi:10.1016/j.tox.2005.05.010.
   Google Scholar
• Hassan AM, Mohamed SR, El-Nekeety AA, Hassan NS, Abdel-Wahhab MA. Aquilegia vulgaris L. extract counteracts oxidative stress and cytotoxicity of fumonisin in rats. Toxicon. 2010;56(1):8–18. doi:10.1016/j.toxicon.2010.03.006.
   Google Scholar
• Riedel S, Abel S, Burger HM, van der Westhuizen L, Swanevelder S, Gelderblom WCA. Differential modulation of the lipid metabolism as a model for cellular resistance to fumonisin B 1-induced cytotoxic effects in vitro. Prostaglandins Leukot Essent Fat Acids. 2016;109:39–51. doi:10.1016/j.plefa.2016.04.006.
   Google Scholar
• Singh MP, Kang SC. Endoplasmic reticulum stress-mediated autophagy activation attenuates fumonisin B1 induced hepatotoxicity in vitro and in vivo. Food Chem Toxicol. 2017;110:371–382. doi:10.1016/j.fct.2017.10.054.
   Google Scholar
• Yin S, Guo X, Li J, Fan L, Hu H. Fumonisin B1 induces autophagic cell death via activation of ERN1-MAPK8/9/10 pathway in monkey kidney MARC-145 cells. Arch Toxicol. 2016;90(4):985–996. doi:10.1007/s00204-015-1514-9.
   Google Scholar
• Ostry V, Malir F, Toman J, Grosse Y. Mycotoxins as human carcinogens-the IARC monographs classification. Mycotoxin Res. 2017;33(1):65–73. doi:10.1007/s12550-016-0265-7.
   Google Scholar
• da Silva EO, Bracarense APFL, Oswald IP. Mycotoxins and oxidative stress: where are we? World Mycotoxin J. 2018;11(1):113–134. doi:10.3920/WMJ2017.2267.
   Google Scholar
• National Research Council. Biological markers in environmental health research. Committee on Biological Markers of the National Research Council. Environ Health Perspect. 1987;74:3–9. doi:10.1289/ehp.74-1474499.
   Google Scholar
• Jones C, Ciacci-Zanella JR, Zhang Y, Henderson G, Dickman M. Analysis of fumonisin B1-induced apoptosis. Environ Health Perspect. 2001;109(suppl 2):315–320. doi:10.1289/ehp.01109s2315.
   Google Scholar
• Ryan PB, Burke TA, Cohen Hubal EA, Cura JJ, McKone TE. Using biomarkers to inform cumulative risk assessment. Environ Health Perspect. 2007;115(5):833–840. doi:10.1289/ehp.9334.
   Google Scholar
• Gelderblom WC, Marasas WF. Controversies in fumonisin mycotoxicology and risk assessment. Hum Exp Toxicol. 2012;31(3):215–235. doi:10.1177/0960327110395338.
   Google Scholar
• Shephard GS, Thiel PG, Sydenham EW, Alberts JF, Cawood ME. Distribution and excretion of a single dose of the mycotoxin fumonisin B1 in a non-human primate. Toxicon off J Int Soc Toxinol. 1994;32(6):735–741. doi:10.1016/0041-0101(94)90342-5.
   Google Scholar
• Marasas WF, Jaskiewicz K, Venter FS, Van Schalkwyk DJ. Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei. S Afr Med J. 1988;74(3):110–114.
   Google Scholar
• Gelderblom WC, Marasas WF, Lebepe-Mazur S, Swanevelder S, Abel S. Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay. Toxicology. 2008;250(2–3):89–95. doi:10.1016/j.tox.2008.06.004.
   Google Scholar
• Chelule PK, Gqaleni N, Dutton MF, Chuturgoon AA. Exposure of rural and urban population in KwaZulu Natal, South Africa, to fumonisin B[sub1] in Maize. Environ Health Perspect. 2001;109(3):253–256. http://10.0.9.3/3434693. doi:10.2307/3434693.
   Google Scholar
• Shephard GS, Van Der Westhuizen L, Sewram V. Biomarkers of exposure to fumonisin mycotoxins: a review. Food Addit Contam. 2007;24(10):1196–1201. doi:10.1080/02652030701513818.
   Google Scholar
• Shetty PH, Bhat RV. Sensitive method for the detection of fumonisin B1 in human urine. J Chromatogr B Biomed Sci Appl. 1998;705(1):171–173. doi:10.1016/S0378-4347(97)00428-3.
   Google Scholar
• Gong YY, Torres-Sanchez L, Lopez-Carrillo L, et al. Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population. Cancer Epidemiol Biomarkers Prev. 2008;17(3):688–694. doi:10.1158/1055-9965.epi-07-2534.
   Google Scholar
• Robinson A, Johnson NM, Strey A, et al. Calcium montmorillonite clay reduces urinary biomarkers of fumonisin B1 exposure in rats and humans. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(5):809–818. doi:10.1080/19440049.2011.651628.
   Google Scholar
• Riley RT, Wang E, Merrill AH, Jr. Liquid chromatographic determination of sphinganine and sphingosine: use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins. AOAC Int. 1994;77(2):533–540. doi:10.1093/jaoac/77.2.533.
   Google Scholar
• Ramljak D, Calvert RJ, Wiesenfeld PW, et al. A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity. Carcinogenesis. 2000;21(8):1537–1546. doi:10.1093/carcin/21.5.537.
   Google Scholar
• Solfrizzo M, Avantaggiato G, Visconti A. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. J Chromatogr B Biomed Sci Appl. 1997;692(1):87–93. doi:10.1016/s0378-4347(96)00502-6.
   Google Scholar
• Merrill AH, Jr, Schmelz EM, Wang E, et al. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J Nutr. 1997;127(5 Suppl):830S–833S. doi:10.1093/jn/127.5.830S.
   Google Scholar
• Wilkins PA, Vaala WE, Zivotofsky D, Twitchell ED. A herd outbreak of equine leukoencephalomalacia. Cornell Vet. 1994;84(1):53–59.
   Google Scholar
• Vendruscolo CP, Frias NC, de Carvalho CB, de Sá LRM, Belli CB, Baccarin RYA. Leukoencephalomalacia outbreak in horses due to consumption of contaminated hay. J Vet Intern Med. 2016;30(6):1879–1881. doi:10.1111/jvim.14588.
   Google Scholar
• Marasas WF, Kellerman TS, Gelderblom WC, Coetzer JA, Thiel PG, van der Lugt JJ. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res. 1988;55(4):197–203.
   Google Scholar
• Smith GWW, Constable PDD, Tumbleson MEE, Rottinghaus GEE, Haschek WMM. Sequence of cardiovascular changes leading to pulmonary edema in swine fed culture material containing fumonisin. Am J Vet Res. 1999;60(10):1292–1300.
   Google Scholar
• Howard PC, Eppley RM, Stack ME, et al. Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ Health Perspect. 2001;109:277–282. doi:10.2307/3435019.
   Google Scholar
• Lemmer ER, Vessey CJ, Gelderblom WC, et al. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study. Carcinogenesis. 2004;25(7):1257–1264. doi:10.1093/carcin/bgh129.
   Google Scholar
• Riedel S, Abel S, Swanevelder S, Gelderblom WCA. Induction of an altered lipid phenotype by two cancer promoting treatments in rat liver. Food Chem Toxicol. 2015;78:96–104. doi:10.1016/j.fct.2015.01.023.
   Google Scholar
• Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27(3):515–524. doi:10.1016/j.ntt.2004.12.007.
   Google Scholar
• Bertero A, Moretti A, Spicer LJ, Caloni F. Fusarium molds and mycotoxins: potential species-specific effects. Toxins (Basel). 2018;10(6):244– 227. doi:10.3390/toxins10060244.
   Google Scholar
• Upadhaya SD, Park MA, Ha JK. Mycotoxins and their biotransformation in the rumen: a review. Asian Australas J Anim Sci. 2010;23(9):1250–1260. doi:10.5713/ajas.2010.r.06.
   Google Scholar
• Missmer SA, Suarez L, Felkner M, et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Heal Perspect. 2006;114(2):237–241. doi:10.1289/ehp.8221.
   Google Scholar
• Gelineau-van Waes J, Voss KA, Stevens VL, Speer MC, Riley RT. Chapter 5 Maternal Fumonisin Exposure as a Risk Factor for Neural Tube Defects. Vol 56. 1st ed. Elsevier Inc.; 2009. doi:10.1016/S1043-4526(08)00605-0.
   Google Scholar
• van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018;80(May):73–84. doi:10.1016/j.reprotox.2018.05.004.
   Google Scholar
• Waes J.-v, Voss KA, Stevens VL, Speer MC, Riley RT. Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res. 2009;56:145.
   Google Scholar
• Al-Dissi A. Toxicology for the equine practitioner. Vet Clin North Am Equine Pract. 2015;31(2):269–279. doi:10.1016/j.cveq.2015.04.009.
   Google Scholar
• Lumsangkul C, Chiang H-I, Lo N-W, Fan Y-K, Ju J-C. Developmental toxicity of mycotoxin fumonisin B1 in animal embryogenesis: an overview. Toxins (Basel). 2019;11(2):114. doi:10.3390/toxins11020114.
   Google Scholar
• Rai M, Jogee PS, Ingle AP. Emerging nanotechnology for detection of mycotoxins in food and feed. Int J Food Sci Nutr. 2015;66(4):363–370. doi:10.3109/09637486.2015.1034251.
   Google Scholar
• Smith GW. Fumonisins. London, UK: Elsevier Inc.; 2018. doi:10.1016/B978-0-12-811410-0.00071-4.
   Google Scholar
• Meyer P. Epigenetics – A Historical Perspective. Vol. 88. Elsevier Ltd; 2018. doi:10.1016/bs.abr.2018.08.003.
   Google Scholar
• Huang D, Cui LQ, Sajid A, et al. The epigenetic mechanisms in Fusarium mycotoxins induced toxicities. Food Chem Toxicol. 2019;123:595–601. doi:10.1016/j.fct.2018.10.059.
   Google Scholar
• Sancak D, Ozden S. Global histone modifications in Fumonisin B1 exposure in rat kidney epithelial cells. Toxicol In Vitro. 2015;29(7):1809–1815. doi:10.1016/j.tiv.2015.07.019.
   Google Scholar
• Bayoglu SO, Karaman EF, Senyildiz M, Ozden S. Effects of fumonisin B1 on global DNA methylation in HK-2 Cells. Toxicol Lett. 2017;280:S200. doi:10.1016/j.toxlet.2017.07.868.
   Google Scholar
• Demirel G, Alpertunga B, Ozden S. Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells. Pharm Biol. 2015;53(9):1302–1310. doi:10.3109/13880209.2014.976714.
   Google Scholar
• Chuturgoon A, Phulukdaree A, Moodley D. Fumonisin B1 induces global DNA hypomethylation in HepG2 cells - an alternative mechanism of action. Toxicology. 2014;315(1):65–69. doi:10.1016/j.tox.2013.11.004.
   Google Scholar
• Theumer MG, Cánepa MC, López AG, Mary VS, Dambolena JS, Rubinstein HR. Subchronic mycotoxicoses in Wistar rats: assessment of the in vivo and in vitro genotoxicity induced by fumonisins and aflatoxin B(1), and oxidative stress biomarkers status. Toxicology. 2010;268(1–2):104–110. doi:10.1016/j.tox.2009.12.007.
   Google Scholar
• Sharma N, He Q, Sharma RP. Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2. Toxicology. 2006;223(3):191–201. doi:10.1016/j.tox.2006.03.021.
   Google Scholar